{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:43:15Z","timestamp":1792568595616,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jbc.2026.113551","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:40:56Z","timestamp":1789195256000},"page":"113551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic and biochemical screens identify MGAT1 as a druggable glycosyltransferase target in STK11-mutant lung cancer"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5523-1223","authenticated-orcid":false,"given":"Kiera M.","family":"Vassallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-nan P.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna B.","family":"Handing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin Z.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7026-2722","authenticated-orcid":false,"given":"Samuel R.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6556-7791","authenticated-orcid":false,"given":"Binzhang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7154-2371","authenticated-orcid":false,"given":"Teng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2223-337X","authenticated-orcid":false,"given":"Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6608-6009","authenticated-orcid":false,"given":"Lei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0878-0465","authenticated-orcid":false,"given":"Katherine","family":"Lazarides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5777-3065","authenticated-orcid":false,"given":"Chengyin","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian B.","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4321-1937","authenticated-orcid":false,"given":"William D.","family":"Mallender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6527-899X","authenticated-orcid":false,"given":"Sining","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3220-9330","authenticated-orcid":false,"given":"Mu-Sen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1602-5354","authenticated-orcid":false,"given":"Alvaro J.","family":"Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5946-8543","authenticated-orcid":false,"given":"Douglas A.","family":"Whittington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8823-5595","authenticated-orcid":false,"given":"Frank J.","family":"Bruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5969-6490","authenticated-orcid":false,"given":"John P.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Maynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2084-6655","authenticated-orcid":false,"given":"Patrick","family":"McCarren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon H.","family":"Come","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-0529","authenticated-orcid":false,"given":"Scott","family":"Throner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4528-2120","authenticated-orcid":false,"given":"Jannik N.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4974-656X","authenticated-orcid":false,"given":"Wenhai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Gueroussov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.113551_bib1","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.113551_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.113551_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jbc.2026.113551_bib4","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2026.113551_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jtho.2021.10.013","article-title":"Diminished efficacy of programmed Death-(Ligand)1 inhibition in STK11- and KEAP1-Mutant lung adenocarcinoma is affected by KRAS mutation status","volume":"17","author":"Ricciuti","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jbc.2026.113551_bib6","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1016\/j.annonc.2020.08.228","article-title":"Immune Checkpoint Inhibitor (ICPI) resistance genes STK11 and KEAP1: a comparative Comprehensive Genomic Profiling (CGP) study","volume":"31","author":"Alexander","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbc.2026.113551_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-024-07943-7","article-title":"CTLA4 blockade abrogates KEAP1\/STK11-related resistance to PD-(L)1 inhibitors","volume":"635","author":"Skoulidis","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.113551_bib8","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 Mutations and PD-1 inhibitor resistance in KRAS-Mutant lung adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2026.113551_bib9","article-title":"AXL targeting restores PD-1 blockade sensitivity of STK11\/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells","volume":"3","author":"Li","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jbc.2026.113551_bib10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/0008-5472.CAN-15-1439","article-title":"STK11\/LKB1 Deficiency Promotes Neutrophil Recruitment and proinflammatory cytokine production to suppress T-cell activity in the lung tumor microenvironment","volume":"76","author":"Koyama","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.113551_bib11","first-page":"CD-18-0689","article-title":"Suppression of STING associated with LKB1 loss in KRAS-driven lung cancer","volume":"9","author":"Kitajima","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2026.113551_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s43018-021-00208-6","article-title":"ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer","volume":"2","author":"Deng","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.jbc.2026.113551_bib13","first-page":"2049","article-title":"Inactivation of AMPK leads to attenuation of antigen presentation and immune evasion in lung adenocarcinoma","volume":"28","author":"Gao","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.113551_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41388-025-03273-8","article-title":"Finding a needle in a haystack: functional screening for novel targets in cancer immunology and immunotherapies","volume":"44","author":"Du","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113551_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.trecan.2021.11.009","article-title":"Tumor immunology CRISPR screening: present, past, and future","volume":"8","author":"Dong","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jbc.2026.113551_bib16","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1158\/0008-5472.CAN-25-0998","article-title":"TNG260 is a small-molecule CoREST inhibitor that sensitizes STK11-Mutant tumors to Anti-PD-1 immunotherapy","volume":"85","author":"Ahronian","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.113551_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1139\/o86-026","article-title":"Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides","volume":"64","author":"Schachter","year":"1986","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113551_bib18","article-title":"Suppression of cancer progression by MGAT1 shRNA knockdown","volume":"7","author":"Zavareh","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.jbc.2026.113551_bib19","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1158\/1078-0432.CCR-20-0778","article-title":"Inhibition of MAN2A1 enhances the immune response to Anti\u2013PD-L1 in human tumors","volume":"26","author":"Shi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.113551_bib20","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1038\/s41467-025-58524-9","article-title":"MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancer","volume":"16","author":"Chi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113551_bib21","doi-asserted-by":"crossref","first-page":"OF1","DOI":"10.1158\/2326-6066.CIR-22-0366","article-title":"Targeting the siglec\u2013sialic acid immune axis in cancer: current and future approaches","volume":"10","author":"L\u00e4ubli","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jbc.2026.113551_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012391","article-title":"Tumor glyco-immunology, glyco-immune checkpoints and immunotherapy","volume":"13","author":"Pinho","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jbc.2026.113551_bib28","doi-asserted-by":"crossref","first-page":"9106","DOI":"10.1200\/JCO.2021.39.15_suppl.9106","article-title":"Impact of STK11 mutation on first-line immune checkpoint inhibitor (ICI) outcomes in a real-world KRAS G12C mutant lung adenocarcinoma cohort","volume":"39","author":"Heist","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.113551_bib29","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","article-title":"Targeted glycan degradation potentiates the anticancer immune response in vivo","volume":"16","author":"Gray","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.113551_bib30","first-page":"2017","article-title":"Sialic acid blockade suppresses tumor growth by enhancing T cell-mediated tumor immunity","volume":"3376","author":"B\u00fcll","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.113551_bib31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ni.f.203","article-title":"Protein-glycan interactions in the control of innate and adaptive immune responses","volume":"9","author":"van Kooyk","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2026.113551_bib37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ijc.20483","article-title":"N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding","volume":"112","author":"Wobus","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2026.113551_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227829","article-title":"Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology","volume":"15","author":"Cawley","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jbc.2026.113551_bib39","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41467-021-22618-x","article-title":"FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113551_bib40","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/hep4.1410","article-title":"Tumor-Selective altered glycosylation and functional attenuation of CD73 in Human hepatocellular carcinoma","volume":"3","author":"Alcedo","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jbc.2026.113551_bib41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1476-4598-13-134","article-title":"RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy","volume":"13","author":"Tominaga","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.113551_bib32","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","article-title":"A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening","volume":"94","author":"Chen","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113551_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ccell.2018.01.009","article-title":"Eradication of triple-negative breast cancer cells by targeting glycosylated PD-L1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2026.113551_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41420-024-02180-3","article-title":"Biological function of sialic acid and sialylation in human health and disease","volume":"10","author":"Zhu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.jbc.2026.113551_bib35","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1021\/acscentsci.5c00939","article-title":"A potent oral sialylation inhibitor augments the immunotherapy in pancreatic ductal adenocarcinoma","volume":"11","author":"Mou","year":"2025","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jbc.2026.113551_bib36","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41467-018-05931-w","article-title":"Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V","volume":"9","author":"Nagae","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113551_bib42","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1021\/cr200060g","article-title":"The methylation effect in medicinal chemistry","volume":"111","author":"Barreiro","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jbc.2026.113551_bib43","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1021\/jm3003697","article-title":"Methyl effects on protein\u2013ligand binding","volume":"55","author":"Leung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113551_bib44","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3390\/ph16081157","article-title":"The magic methyl and its tricks in drug discovery and development","volume":"16","author":"de Pinheiro","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jbc.2026.113551_bib45","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/jm1013693","article-title":"Synopsis of some recent tactical application of bioisosteres in drug design","volume":"54","author":"Meanwell","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113551_bib46","doi-asserted-by":"crossref","first-page":"12290","DOI":"10.1021\/acs.jmedchem.0c00530","article-title":"Amide bond bioisosteres: strategies, synthesis, and successes","volume":"63","author":"Kumari","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113551_bib47","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1007\/s11033-022-07359-4","article-title":"N-glycosylation, a leading role in viral infection and immunity development","volume":"49","author":"Pandey","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jbc.2026.113551_bib48","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41590-024-02015-4","article-title":"Next-generation combination approaches for immune checkpoint therapy","volume":"25","author":"Goswami","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2026.113551_bib49","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41571-025-01035-9","article-title":"The next generation of immunotherapies for lung cancers","volume":"22","author":"Zhao","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.113551_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41568-022-00544-4","article-title":"Mechanisms driving the immunoregulatory function of cancer cells","volume":"23","author":"van Weverwijk","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2026.113551_bib51","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s42255-020-00316-0","article-title":"The hexosamine biosynthesis pathway is a targetable liability in KRAS\/LKB1 mutant lung cancer","volume":"2","author":"Kim","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jbc.2026.113551_bib52","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1158\/1538-7445.AM2025-5391","article-title":"Abstract 5391: the hexosamine biosynthetic pathway promotes metastatic potential upon glutamine deprivation in STK11 null KRAS-driven lung adenocarcinoma","volume":"85","author":"Prior","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.113551_bib53","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-022-29205-8","article-title":"CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity","volume":"13","author":"Joung","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.113551_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg3072","article-title":"Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies","volume":"14","author":"Greco","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2026.113551_bib55","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.trecan.2023.11.009","article-title":"Targeting myeloid cells for cancer immunotherapy: Siglec-7\/9\/10\/15 and their ligands","volume":"10","author":"Boelaars","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jbc.2026.113551_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178804","article-title":"N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearance","volume":"9","author":"Hollander","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2026.113551_bib57","article-title":"N-glycosylation engineering in chimeric antigen receptor T cells enhances anti-tumor activity","author":"De Bousser","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2026.113551_bib58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.immuni.2018.01.006","article-title":"Interleukin-10 directly inhibits CD8+ T cell function by enhancing N-Glycan branching to decrease Antigen sensitivity","volume":"48","author":"Smith","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2026.113551_bib59","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2025.02.007","article-title":"Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells","volume":"58","author":"Luo","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2026.113551_bib60","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41586-023-06575-7","article-title":"The PTPN2\/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity","volume":"622","author":"Baumgartner","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.113551_bib61","doi-asserted-by":"crossref","first-page":"14053","DOI":"10.1074\/jbc.RA120.014784","article-title":"Point mutations that inactivate MGAT4D-L, an inhibitor of MGAT1 and complex N-glycan synthesis","volume":"295","author":"Akintayo","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113551_bib62","doi-asserted-by":"crossref","DOI":"10.1097\/IN9.0000000000000035","article-title":"N-linked glycans: an underappreciated key determinant of T cell development, activation, and function","volume":"5","author":"Abdelbary","year":"2023","journal-title":"Immunometabolism"},{"key":"10.1016\/j.jbc.2026.113551_bib63","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/35055582","article-title":"Negative regulation of T-cell activation and autoimmunity by Mgat5N-glycosylation","volume":"409","author":"Demetriou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.113551_bib64","doi-asserted-by":"crossref","first-page":"16120","DOI":"10.1021\/acs.jmedchem.3c01517","article-title":"Imidazolone as an amide bioisostere in the development of \u03b2-1,3-N-Acetylglucosaminyltransferase 2 (B3GNT2) inhibitors","volume":"66","author":"Jackson","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.113551_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1158\/1535-7163.MCT-22-0409","article-title":"Ubiquitinated PCNA drives USP1 synthetic lethality in cancer","volume":"22","author":"Simoneau","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2026.113551_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1107\/S2059798323003595","article-title":"The CCP4 suite: integrative software for macromolecular crystallography","volume":"79","author":"Agirre","year":"2023","journal-title":"Acta Crystallogr. Sect. D"},{"key":"10.1016\/j.jbc.2026.113551_bib25","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1093\/emboj\/19.20.5269","article-title":"X-ray crystal structure of rabbit n-acetylglucosaminyltransferase I: catalytic mechanism and a new protein superfamily","volume":"19","author":"\u00dcnligil","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2026.113551_bib26","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2026.113551_bib27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. Sect. D"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826024233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826024233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:24:24Z","timestamp":1792567464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826024233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":64,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0021925826024233"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113551","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and biochemical screens identify MGAT1 as a druggable glycosyltransferase target in STK11-mutant lung cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"113551"}}